Contract Specifications

Instrument Type Underlying Expiry Date Option Type Strike Price Market Lot

Price Information

Last Price Today's Change Underlying value
 0.00   [0]  0.00
Open  0.00
Prev Close  0.00
Today's Range  0.00 - 0.00
Average Price  0.00
Buy(size)  0.00
Sell(size)  0.00

Turnover Open Interest Information

Volume Turnover Open Interest Change in OI %Change in OI
 0.00  0.00  0.00   [0.00]   [0]
FIIs trend in derivatives
Instruments Buy[Rs.Cr] Sell[Rs.Cr] Net Positions [Rs.Cr] Contracts ['000s] OI Value[Rs.Cr]
Index Futures 1,369.63 2,197.61 [827.98] 258.78 10,518.55
Index Options 10,515.80 9,607.38 908.42 1,493.47 60,433.08
Stock Futures 1,699.20 2,458.38 [759.18] 1,293.08 48,186.30
Stock Options 1,669.68 1,653.66 16.02 60.64 2,238.82

Nifty slips below 10,500 mark; SBI stocks gain

India Infoline News Service May-23-2018

Indices slipped sharply in the early trades led by selling seen across the board.

CCI provides clearance to $66bn Bayer-Monsanto deal

India Infoline News Service May-23-2018

The acquisition of Monsanto would create a global leader in agriculture with a broad portfolio across agro products and chemicals for Bayer.

Amazon may buy ~10% stake in Future Retail

India Infoline News Service May-23-2018

The deal is expected to value the Future Retail at US$6bn (~Rs40,000cr)

Broker Radar for May 23

India Infoline News Service May-23-2018

Check out the stock commentaries and recommendations from foreign brokerage houses.

NCLT allows CoC to consider revised bid of UltraTech

India Infoline News Service May-23-2018

Dalmia Bharat unwilling to revise its offer; next hearing by NCALT scheduled for July 10.

Top stocks in focus today: Cipla, Grasim, HPCL, Jet Airways, Tata Motors, SBI, Bata, Sun Pharma

India Infoline News Service May-23-2018

These companies will be in focus during trade today based on recent and latest news developments.

Indian Equities News

Natco in focus ahead of Q4 numbers, to benefit from delay in Dr. Reddy’s gCopaxone

India Infoline News Service / 10:30, May 23, 2018

The delay in Dr. Reddy's gCopaxone will benefit Natco as it launched the drug in October 2017 and has only one generic competitor in this product category.